Sabrina Martucci Johnson | President and Chief Executive Officer |
Lisa Walters-Hoffert | Chief Financial Officer |
Christine Mauck | Medical Director |
David Friend | Chief Scientific Officer |
John Fair | Chief Business Officer |
Yasmeen Rahimi | ROTH Capital Partners |
Jason Kolbert | Dawson James Securities |
Joanne Lee | Maxim Group LLC |
James Molloy | Alliance Global Partners |
Brian Marckx | Zacks Investments Research |
Welcome to the conference call hosted by Daré Bioscience to discuss financial results for the quarter ended June 30, 2019, and to provide a general business update. This call is being recorded. My name is Joel, and I will be your operator today.
With us today are Sabrina Martucci Johnson, Daré's President and Chief Executive Officer; Lisa Walters-Hoffert, Daré's Chief Financial Officer; Dr. Christine Mauck, Daré's Medical Director; and Dr.